Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
942.55
3.35 (0.36%) Cadila Healthcare board recommends Dividend
Date: 16-05-2014Cadila Healthcare has informed that the Board of Directors of the company at its meeting held on May 16, 2014 have recommended a dividend of Rs. 9 (@ 180%) per equity share of Rs 5 each for the financial year ended on March 31, 2014.
The above information is a part of company’s filings submitted to BSE.